<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03713762</url>
  </required_header>
  <id_info>
    <org_study_id>PBBCM</org_study_id>
    <nct_id>NCT03713762</nct_id>
  </id_info>
  <brief_title>Peribulbar Block: Lidocaine-bupivacaine vs Lidocaine-bupivacaine-fentanyl</brief_title>
  <official_title>Anesthesia With Peribulbar Block: Lidocaine-bupivacaine vs Lidocaine-bupivacaine-fentanyl</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Docente la Trinidad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Medico Docente la Trinidad</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ophthalmological procedures such as cataract extraction can be carried out with a peribulbar
      block (PBB). The advantages of this anesthetic technique include a lower incidence of
      coughing, unwanted movements and emesis during awakening, in addition to providing adequate
      postoperative analgesia. The researchers want to investigate whether the use of fentanyl
      citrate by peribulbar route, when administered with a local anesthetic, shortens the
      anesthetic latency, interfere with the degree of akinesia and if provides greater
      postoperative analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Article Type. Clinical trial study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2009</start_date>
  <completion_date type="Actual">November 30, 2009</completion_date>
  <primary_completion_date type="Actual">November 30, 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Latency period (lost of corneal reflex)</measure>
    <time_frame>10 minutes until the start of surgery</time_frame>
    <description>lost of corneal reflex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular akinesia: movements of extraocular muscles</measure>
    <time_frame>10 minutes until the start of surgery</time_frame>
    <description>movements of extraocular muscles</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative pain</measure>
    <time_frame>2 Hours</time_frame>
    <description>Analogous visual scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>2 hours</time_frame>
    <description>bleeding or bruise</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Group 1 LB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peribulbar block 1 was performed received 100 mg of lidocaine 5% and 15 mg of bupivacaine 0.5% for a total volume of the anesthetic mixture of 5 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 LBF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peribulbar block 2 was performed received 100 mg of lidocaine 5%, 15 mg of 0.5% bupivacaine and 50 mcg of fentanyl citrate for a total volume of the anesthetic mixture of 6 ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>peribulbar block 1 lidocaine/bupivacaine</intervention_name>
    <description>Peribulbar block: 100 mg of lidocaine 5% and 15 mg of bupivacaine 0.5% for a total volume of the anesthetic mixture of 5 ml.</description>
    <arm_group_label>Group 1 LB</arm_group_label>
    <other_name>lidocaine/bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>peribulbar block 2 lidocaine/bupivacaine/fentanyl</intervention_name>
    <description>Peribulbar block: 100 mg of lidocaine 5%, 15 mg of 0.5% bupivacaine and 50 mcg of fentanyl citrate for a total volume of the anesthetic mixture of 6 ml.</description>
    <arm_group_label>Group 2 LBF</arm_group_label>
    <other_name>lidocaine/bupivacaine/fentanyl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients scheduled for cataract surgery (Cataract Extracapsular Extraction)

          -  With indication of regional anesthesia with peribulbar block

          -  Physical status ASA I or II

          -  Patients between 45 and 90 years of age

        Exclusion Criteria:

          -  Allergic to amide-type anesthetics and fentanyl citrate

          -  Patients with a history of woody thorax

          -  Patients with uncompensated systemic diseases

          -  Patients in whom it was necessary to change the anesthetic technique due to
             insufficient analgesia or those in which the administration of intravenous analgesics
             was required during the operative period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 11, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2018</study_first_posted>
  <last_update_submitted>October 20, 2018</last_update_submitted>
  <last_update_submitted_qc>October 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Medico Docente la Trinidad</investigator_affiliation>
    <investigator_full_name>Leopoldo Wulff</investigator_full_name>
    <investigator_title>Principal Investigator, anesthesiologist.</investigator_title>
  </responsible_party>
  <keyword>Peribulbar block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

